Subscribe To
Synchrony (syf) beats q3 earnings and revenue estimates
Synchrony (SYF) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estima...
October 24, 2023, 9:01 am
Archrock announces timing for third quarter 2023 results
HOUSTON, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) (“Ar...
October 24, 2023, 7:00 am
Mallinckrodt to present data on terlivaz® (terlipressin) for injection in adult patients with hepatorenal syndrome (hrs) at the american college of gastroenterology (acg) annual scientific meeting
– Findings from two clinical studies and one health economic database analysis provide insight into HRS treatment outcomes with TERLIVAZ,1 patients'...
October 22, 2023, 3:05 pm
Credit agricole: unraveling the reasons behind the usd's recent underperformance
Synopsis: Despite its historical strength and the 'USD smile' framework, the USD's recent subdued performance has left market observers questioning th...
October 20, 2023, 7:32 pm
Ipo update: chromocell therapeutics seeks $8.7 million in micro-ipo
chromocell Therapeutics Corporation has filed for an $8.7 million IPO to develop its treatment for
October 19, 2023, 5:31 pm
Will rising expenses affect synchrony's (syf) q3 earnings?
Synchrony's (SYF) third-quarter results are likely to reflect lower net interest margins and higher tot...
October 19, 2023, 2:17 pm
America movil, s.a.b. de c.v. (amx) q3 2023 earnings call transcript
America Movil, S.A.B. de C.V. (NYSE:AMX ) Q3 2023 Earnings Conference Call October 18, 2023 11:00 AM ET Company Participants Daniela Lecuona - Head of...
October 18, 2023, 9:19 pm
Why ardelyx stock popped today
Late yesterday, Ardelyx announced that the FDA has approved its first-in-class chronic kidney disease d...
October 18, 2023, 4:31 pm
Lbrt vs. aroc: which stock should value investors buy now?
Investors with an interest in Oil and Gas - Field Services stocks have likely encountered both Liberty Oilfield Services (LBRT) and Ar...
October 18, 2023, 12:47 pm
Zyversa therapeutics announces a publication in the peer-reviewed journal, aging, linking inflammasome nlrp3 activation with age-related structural changes in the kidney and reduced kidney function
chronic kidney disease is most common in people 65 years and older. NLRP3 inflammasomes signaling in th...
October 18, 2023, 11:05 am
Ardelyx wins long battle for fda approval of kidney-disease treatment
Ardelyx Inc. ARDX, -0.58% on Tuesday won its long fight for U.S. regulatory approval of a treatment designed to help patients with ...
October 17, 2023, 7:24 pm
South african platinum producer tharisa says fy23 output down due to operational challenges
(Kitco News) - South African platinum group metals (PGM) producer Tharisa (LSE: THS) (JSE: THA) announced today that its PGM production for the year e...
October 17, 2023, 4:04 pm
Ocean biomedical (nasdaq: ocea) announces enrollment of patients for phase 1b study for chronic hepatitis b treatment in 50-50 joint venture with virion therapeutics
Providence, Rhode Island, Oct. 17, 2023 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the deve...
October 17, 2023, 12:01 pm
Tharisa ends year with more cash, extends timeline for karo platinum project
Tharisa PLC (LSE:THS, JSE:THA, OTC:TIHRF) said its co-product model showed its resilience in the year to September, as ...
October 17, 2023, 3:23 am
Terns pharmaceuticals announces global phase 1 clinical trial design of tern-701 for the treatment of chronic myeloid leukemia
Investigational New Drug application cleared by U.S. Food and Drug Administration Design leverages insights from partner’s ongoing Phase 1 trial in ...
October 16, 2023, 12:05 pm
: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is...
October 16, 2023, 11:11 am
Lyra therapeutics announces appointment of ronan o’brien as chief legal officer
WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotec...
October 16, 2023, 11:00 am
Mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023
Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...
October 13, 2023, 8:10 pm
Longeveron announces closing of $4 million registered direct offering priced at-the-market under nasdaq rules
MIAMI, Oct. 13, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company d...
October 13, 2023, 8:05 pm
Should value investors buy synchrony financial (syf) stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe...
October 13, 2023, 11:17 am